2024-06-25 12:14:00 ET
Summary
- Pfizer CEO announced testing of three new weight loss drugs, one with a different mechanism than current GLP-1 agonists.
- Consumer confidence slightly down in May, with expectations index falling.
- Tesla recalls thousands of Cybertrucks over wiper defect.
- Hedge funds selling chip stocks and tech, while net buying financials.
Listen below or on the go on Apple Podcasts and Spotify
Weight loss drug candidate will differ from popular GLP-1s. (0:16) Tesla recalls thousands of Cybertrucks . (3:09) Hedge funds keep cashing in on tech. (3:55)...
Read the full article on Seeking Alpha
For further details see:
Wall Street Lunch: Pfizer Looks To Take Next Step In Weight-Loss Drugs